Received a letter from the New York Stock Exchange (the "NYSE") dated January 24, 2024, notifying the Company that (i) it is below compliance standards due to the trading price of the Company's American depositary shares (the "ADSs"), (ii) the applicable cure period for the Company to regain compliance will expire on July 24, 2024, and (iii) with respect to the previous NYSE letter dated September 28, 2023 regarding ADS trading price, the receipt of which was announced by the Company on October 2, 2023, the NYSE confirmed that the Company had regained compliance as of November 30, 2023.
